Colorectal Cancer RECHALLENGE
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Primary Objective: * To demonstrate that re-challenge with an oxaliplatin based regimen (modified FOLFOX-6) will provide a clinical disease control rate (DCR) of at least 20% at the end of the chemotherapy. Secondary Objective: * To evaluate other measures of tumour’s responses and safety.
创建时间：
2009-10-15
